This page lists the SEC filings reported by Eventide Asset Management.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2019-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | Entasis Therapeutics Holdings Inc. | 879,541 | 6.7% | EDGAR |
| SC 13G | 2019-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | Magenta Therapeutics, Inc. | 2,650,808 | 8.0% | EDGAR |
| SC 13G | 2019-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | SUTRO BIOPHARMA, INC. | 1,244,895 | 5.4% | EDGAR |
| SC 13G/A | 2018-03-09 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 27,719,410 | 19.9% | EDGAR |
| SC 13G/A | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | VERACYTE, INC. | 2,133,500 | 6.3% | EDGAR |
| SC 13G/A | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | Tracon Pharmaceuticals, Inc. | 900,000 | 5.1% | EDGAR |
| SC 13G/A | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 2,719,410 | 9.3% | EDGAR |
| SC 13G/A | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | COLLEGIUM PHARMACEUTICAL, INC | 2,207,610 | 6.8% | EDGAR |
| SC 13G/A | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | 8point3 Energy Partners LP | 1,461,400 | 5.2% | EDGAR |
| SC 13G | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | VICAL INC | 1,700,000 | 9.1% | EDGAR |
| SC 13G | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | SUNESIS PHARMACEUTICALS INC | 2,265,455 | 6.6% | EDGAR |
| SC 13G | 2018-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | KalVista Pharmaceuticals, Inc. | 709,000 | 6.6% | EDGAR |
| SC 13G | 2017-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | 8point3 Energy Partners LP | 1,553,700 | 5.5% | EDGAR |
| SC 13G | 2017-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | Tracon Pharmaceuticals, Inc. | 865,526 | 5.5% | EDGAR |
| SC 13G | 2017-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | COLLEGIUM PHARMACEUTICAL, INC | 2,077,751 | 7.3% | EDGAR |
| SC 13G | 2017-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 2,719,410 | 9.3% | EDGAR |
| SC 13G | 2017-02-13 | EVENTIDE ASSET MANAGEMENT, LLC | Zosano Pharma Corp | 272,000 | 1.6% | EDGAR |
| SC 13G/A | 2016-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | VERACYTE, INC. | 2,252,000 | 8.1% | EDGAR |
| SC 13G | 2016-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | Zosano Pharma Corp | 888,300 | 7.4% | EDGAR |
| SC 13G | 2016-02-12 | EVENTIDE ASSET MANAGEMENT, LLC | COLLEGIUM PHARMACEUTICAL, INC | 1,401,001 | 6.0% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.